12 July 2017

Our 2017 Drug Discovery & Development Symposium in Berlin was a success

Berlin close-up headshots.JPG

This summer’s Drug Symposium was a special event, having now received feedback from all those who attended. Just over 90 delegates actively participated in the Symposium, ranging from academia, regulatory and pharmaceutical backgrounds – 78% of all sessions were rated as excellent and 21% rated as good.

Our newly established Pharma Task Force also held its second meeting with overwhelming attendance and received an overwhelming offer of support from both Academia, Pharma and Regulators.


The PVRI Digital Clinic, a state of the art e-learning course for PH clinicians, was also announced. We are now looking for up to 15 members to test this course before its launch in Singapore. If you are interested in participating in the testing of the e-learning course, please email: Admin@pvrinstitute.org.

Pharma Task Force holds its second meeting

Our Pharma Task Force held its second meeting at the symposium, with some exciting new initiatives prepared for the coming months. If you would like to get involved or would like to know more about the Task Force, please visit the homepage here.

A note from our Chief Executive, Stephanie Barwick

Thank you to everyone for attending our recent Drug Symposium in the historic city of Berlin. Overwhelming positive feedback was received by all those who participated which is testament to the great scientific programme put together by Ardi Ghofrani, Stuart Rich and John Newman. When glancing at the programme, most of us may have felt that a 40-minute discussion time following each presentation could be a long time, but as it turned out, debates and discussions were so stimulating we didn’t have enough time. Thank you to all for your active participation. I look forward to seeing many of you in Singapore in January 2018!

Comments (0)

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI